Natera Cash on Hand 2014-2025 | NTRA
- Natera cash on hand for the quarter ending March 31, 2025 was $0.992B, a 12.31% increase year-over-year.
- Natera cash on hand for 2024 was $0.968B, a 10.16% increase from 2023.
- Natera cash on hand for 2023 was $0.879B, a 2.16% decline from 2022.
- Natera cash on hand for 2022 was $0.898B, a 1.76% decline from 2021.
Natera Annual Cash on Hand (Millions of US $) |
|
---|---|
2024 | $968 |
2023 | $879 |
2022 | $898 |
2021 | $915 |
2020 | $737 |
2019 | $441 |
2018 | $158 |
2017 | $119 |
2016 | $147 |
2015 | $231 |
2014 | $88 |
2013 | $31 |
Natera Quarterly Cash on Hand (Millions of US $) |
|
---|---|
2025-03-31 | $992 |
2024-12-31 | $968 |
2024-09-30 | $922 |
2024-06-30 | $887 |
2024-03-31 | $883 |
2023-12-31 | $879 |
2023-09-30 | $937 |
2023-06-30 | $736 |
2023-03-31 | $812 |
2022-12-31 | $898 |
2022-09-30 | $521 |
2022-06-30 | $639 |
2022-03-31 | $752 |
2021-12-31 | $915 |
2021-09-30 | $1,024 |
2021-06-30 | $580 |
2021-03-31 | $654 |
2020-12-31 | $737 |
2020-09-30 | $810 |
2020-06-30 | $571 |
2020-03-31 | $406 |
2019-12-31 | $441 |
2019-09-30 | $238 |
2019-06-30 | $238 |
2019-03-31 | $128 |
2018-12-31 | $158 |
2018-09-30 | $170 |
2018-06-30 | $89 |
2018-03-31 | $119 |
2017-12-31 | $119 |
2017-09-30 | $146 |
2017-06-30 | $103 |
2017-03-31 | $117 |
2016-12-31 | $147 |
2016-09-30 | $184 |
2016-06-30 | $216 |
2016-03-31 | $232 |
2015-12-31 | $231 |
2015-09-30 | $223 |
2015-06-30 | $62 |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | |
2013-12-31 | $31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $18.548B | $1.697B |
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $148.115B | 27.47 |
CVS Health (CVS) | United States | $75.901B | 9.43 |
Elevance Health (ELV) | United States | $65.016B | 8.74 |
Cencora (COR) | United States | $56.164B | 19.54 |
DiDi Global (DIDIY) | China | $25.650B | 27.25 |
Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
BioMerieux (BMXMF) | France | $17.068B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
ICON (ICLR) | Ireland | $14.957B | 14.39 |
CochLear (CHEOY) | Australia | $13.609B | 0.00 |
Solventum (SOLV) | United States | $12.725B | 13.47 |
Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
Revvity (RVTY) | United States | $11.135B | 19.32 |
Viatris (VTRS) | United States | $10.786B | 3.71 |
Avantor (AVTR) | United States | $9.547B | 13.87 |
Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
HealthEquity (HQY) | United States | $8.282B | 36.28 |
Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $5.183B | 30.52 |
Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
Sotera Health (SHC) | United States | $3.446B | 19.58 |
Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
Organon (OGN) | United States | $2.636B | 2.80 |
GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
Concentras Parent (CON) | United States | $2.589B | 14.96 |
Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
Progyny (PGNY) | United States | $1.957B | 43.08 |
PACS (PACS) | United States | $1.757B | 0.00 |
Premier (PINC) | United States | $1.749B | 13.27 |
GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
Ardent Health (ARDT) | United States | $1.532B | 6.53 |
Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
Agilon Health (AGL) | United States | $0.799B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
CareDx (CDNA) | United States | $0.708B | 11.06 |
Embecta (EMBC) | United States | $0.628B | 4.23 |
So-Young (SY) | China | $0.507B | 0.00 |
InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
Nutex Health (NUTX) | United States | $0.474B | 7.18 |
Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
Omada Health (OMDA) | $0.468B | 0.00 | |
LifeMD (LFMD) | United States | $0.464B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
SBC Medicals (SBC) | United States | $0.454B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
Enhabit (EHAB) | United States | $0.337B | 27.75 |
Oncology Institute (TOI) | United States | $0.323B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
Beauty Health (SKIN) | United States | $0.213B | 0.00 |
DocGo (DCGO) | United States | $0.145B | 23.67 |
Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
KindlyMD (NAKA) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
Biodesix (BDSX) | United States | $0.057B | 0.00 |
ModivCare (MODV) | United States | $0.043B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |